HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Nakaraang pagsara
$81.51
Sakop ng araw
$78.84 - $81.22
Sakop ng taon
$23.95 - $83.61
Market cap
12.85B USD
Average na Volume
2.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 156.72M | 17.12% |
Gastos sa pagpapatakbo | 96.81M | 57.06% |
Net na kita | -128.61M | 8.45% |
Net profit margin | -82.06 | 21.83% |
Kita sa bawat share | -0.61 | 15.49% |
EBITDA | -157.31M | -7.98% |
Aktuwal na % ng binabayarang buwis | -0.17% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.24B | -9.94% |
Kabuuang asset | 3.03B | -1.56% |
Kabuuang sagutin | 2.42B | -0.14% |
Kabuuang equity | 617.97M | — |
Natitirang share | 161.97M | — |
Presyo para makapag-book | 21.23 | — |
Return on assets | -13.31% | — |
Return on capital | -15.13% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -128.61M | 8.45% |
Cash mula sa mga operasyon | -131.44M | -14.30% |
Cash mula sa pag-invest | 91.34M | 126.80% |
Cash mula sa financing | 81.22M | -83.63% |
Net change in cash | 41.04M | 1.05% |
Malayang cash flow | -71.55M | -55.03% |
Tungkol
Ionis Pharmaceuticals, Inc. is a biotechnology that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
Itinatag
1989
Headquarters
Website
Mga Empleyado
1,069
